These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 7048621

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Acylated streptokinase--plasminogen complex in patients with acute myocardial infarction.
    Walker ID, Davidson JF, Rae AP, Hutton I, Lawrie TD.
    Thromb Haemost; 1984 Apr 30; 51(2):204-6. PubMed ID: 6377564
    [Abstract] [Full Text] [Related]

  • 4. On the fibrinolytic and thrombolytic properties of active-site p-anisoylated streptokinase-plasminogen complex (BRL 26921).
    Matsuo O, Collen D, Verstraete M.
    Thromb Res; 1981 Nov 15; 24(4):347-58. PubMed ID: 7038976
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Streptokinase and anisoylated streptokinase plasminogen complex. Their action on haemostasis in human volunteers.
    Staniforth DH, Smith RA, Hibbs M.
    Eur J Clin Pharmacol; 1983 Nov 15; 24(6):751-6. PubMed ID: 6350023
    [Abstract] [Full Text] [Related]

  • 7. Acylated derivatives of streptokinase-plasminogen activator complex as thrombolytic agents in a dog model of aged venous thrombosis.
    Dupe RJ, Green J, Smith RA.
    Thromb Haemost; 1985 Feb 18; 53(1):56-9. PubMed ID: 3887635
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The systemic fibrinolytic effect of BRL 26921 during the treatment of acute peripheral arterial occlusions.
    Earnshaw JJ, Westby JC, Makin GS, Hopkinson BR.
    Thromb Haemost; 1986 Apr 30; 55(2):259-62. PubMed ID: 3520938
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics and effects on fibrinolytic and coagulation parameters of two doses of recombinant tissue-type plasminogen activator in healthy volunteers.
    Verstraete M, Su CA, Tanswell P, Feuerer W, Collen D.
    Thromb Haemost; 1986 Aug 20; 56(1):1-5. PubMed ID: 3095944
    [Abstract] [Full Text] [Related]

  • 14. Proteolysis of fibrinogen in healthy volunteers following major and minor vivo plasminogen activation.
    Prowse CV, Dawes J, Lane DA, Ireland H, Knight I.
    Thromb Res; 1982 Jul 01; 27(1):91-7. PubMed ID: 6750837
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Fibrinolytic treatment by infusion of streptokinase-plasminogen-complex (activator): laboratory effects.
    Martin H, Auel H, Riedel C.
    Behring Inst Mitt; 1986 Feb 01; (79):263-71. PubMed ID: 2424424
    [Abstract] [Full Text] [Related]

  • 17. [The thrombolytic activity of acylated activator complexes of plasmin-streptokinase with different rates of reactivation].
    Bashkov GV, Aĭsina RB, Kazanskaia NF, Makarov VA, Sirotenko AV, Popova GIu, Zhitkova IuV.
    Farmakol Toksikol; 1991 Feb 01; 54(2):46-50. PubMed ID: 1884796
    [Abstract] [Full Text] [Related]

  • 18. [T-PA and APSAC, new fibrinolytics].
    Med Monatsschr Pharm; 1986 Nov 01; 9(11):326-7. PubMed ID: 3100917
    [No Abstract] [Full Text] [Related]

  • 19. Low dose intra-arterial streptokinase and acylated plasminogen-streptokinase activator complex: a retrospective review of two thrombolytic regimes in recent peripheral arterial ischaemia.
    Earnshaw JJ, Westby JC, Makin GS, Hopkinson BR.
    Eur J Vasc Surg; 1987 Jun 01; 1(3):151-8. PubMed ID: 3332631
    [Abstract] [Full Text] [Related]

  • 20. Pharmacology of fibrinolysis.
    Haire WD.
    Chest; 1992 Apr 01; 101(4 Suppl):91S-97S. PubMed ID: 1555484
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.